万维提示：
1、投稿方式：在线投稿。
2、期刊网址：
https://www.clinexprheumatol.org/default.asp
3、投稿网址：
https://www.clinexprheumatol.org/manuscript-submission.asp
4、官网邮箱：bombardieri@clinexprheumatol.org（主编）
（更多邮箱信息请查看期刊官网信息）
5、期刊刊期：月刊，一年出版12期。
2022年1月17日星期一
投稿须知【官网信息】
Guidelines for Authors
Clinical and Experimental Rheumatology is a bi-monthly journal which publishes original papers on clinical or experimental research pertinent to the rheumatic diseases; work on connective tissue diseases and other immune disorders also are within the journal's scope. Contributors may submit Editorials, Original Articles, Rapid Papers, Review Articles, Case Reports and Letters to the Editor. Every issue also contains a section dedicated to the area of Pediatric Rheumatology.
Articles will be considered for publication on the condition that they are submitted solely to Clinical and Experimental Rheumatology. The statements and opinions expressed in the articles and communications are those of the Authors, and the Editors and publisher disclaim any responsibility or liability for these statements.
Manuscripts will be acknowledged on receipt. All submitted articles will be read by the Editors and sent to two or more members of the Editorial Board or outside consultants for formal review. The referees' comments will be forwarded to the Authors.
A charge of €100.00 per printed page will be assessed for all articles published. Instructions for payment will be sent to authors along with the proofs. There is no charge for solicited articles.
Accepted articles may be published online free to view at a cost of €500.00, that the Authors must bear; instructions for payment will be sent to authors along with the proofs.
Table of Contents
Submission of Manuscripts
Types of Articles
References
Tables and Figures
Send submissions to:
Submission of Manuscripts
Please click on the "Submission on line" button on top of this page to submit a manuscript, and follow the instructions on how to submit a manuscript.
Manuscripts should be accompanied by a cover letter containing:
a statement by the Authors that the article has not been published and is not under consideration for publication elsewhere;
information on prior publication or the submission elsewhere of any part of the work (note: if any of the material in the article has already been published in other than abstract form, enclose a copy of the previous publication);
a statement of financial or other relationships that could lead to a conflict of interest;
a statement that the manuscript has been read and approved by all of the authors;
in cases of excessive authorship (more than 6 authors for an original article, or more than 3 for a case report) an explanation of the contribution of each author must be provided;
the letter may also give information regarding the type of article the manuscript represents and why the authors feel it would be interest to the readers of Clinical and Experimental Rheumatology;
The manuscript must be accompanied by copies of permissions to reproduce published material, report sensitive personal information, to use illustrations of identifiable persons, or to name persons for their contributions.
In preparing their manuscripts authors should adhere to the norms laid out in the Uniform Requirements for Manuscripts Submitted to Biomedical Journals (JAMA 1993; 269: 2282-6). The style should be clear and concise, and authors not fluent in English should have their paper corrected by a native English speaker, preferably one with a scientific background.
Manuscripts must be typed double-spaced with wide margins (at least 2 cm on all sides). Single-spaced material is not acceptable. Each manuscript should contain in one single file: one page with title, authors names and all affiliations; one page with abstract and key words; text; acknowledgements; references; individual tables; and legends. Number the pages consecutively, beginning with the title page.
……
更多详情：
https://www.clinexprheumatol.org/guidelines-authors.asp
